An observational study in Subarachnoid Hemorrhage, Cerebral Aneurysm and Amnesia, sponsored by Tohoku University. Completed. Per ClinicalTrials.gov, last updated 2013-08-09.
Sponsored by Tohoku University · Observational
To clarify whether amnesia after treatment of anterior communicating aneurysm (ACoA)is related to infarcts caused by occlusion or damage of the perforating artery of the ACoA, we used 3.0-T 3D high resolution MR imaging to identify and localize infarcts in patients with amnesia following treatment of ACoA aneurysm.
Cohort register is made by experienced neuropsychologists in our institute.
MR imaging and data storage is in the department of diagnostic radiology of our institute.
MR images are evaluated by two neuroradiologists using a work station.
510 studies on the registry are indexed under Subarachnoid Hemorrhage; 128 are open to participants now.
This study's enrollment of 14 is below the median of 120 across 226 observational studies indexed under Subarachnoid Hemorrhage.
Browse Subarachnoid Hemorrhage studies →Tohoku University is the lead sponsor of 8 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with amnesia following surgical treatment of the ACoA aneurysm.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Clinical diagnosis of Amnesia
Exclusion Criteria:
Severe decreased intellectual function
cerebral infarction identified and localized in the basal forebrain on MR imaging
Time frame: within 15 months from the aneurysmal treatment(an expected average 4 months)
No study locations are listed for this record.
This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tohoku University